Phil E M Smith

9.4k total citations
107 papers, 2.6k citations indexed

About

Phil E M Smith is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, Phil E M Smith has authored 107 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Psychiatry and Mental health, 40 papers in Pediatrics, Perinatology and Child Health and 13 papers in Neurology. Recurrent topics in Phil E M Smith's work include Epilepsy research and treatment (50 papers), Pharmacological Effects and Toxicity Studies (36 papers) and Neuroscience and Neuropharmacology Research (10 papers). Phil E M Smith is often cited by papers focused on Epilepsy research and treatment (50 papers), Pharmacological Effects and Toxicity Studies (36 papers) and Neuroscience and Neuropharmacology Research (10 papers). Phil E M Smith collaborates with scholars based in United Kingdom, United States and Australia. Phil E M Smith's co-authors include Peter Calverley, R. H. T. Edwards, R. H. T. Edwards, John M. Wild, William Owen Pickrell, Markus Reuber, Rhys H. Thomas, Rebecca Mayor, Mark I. Rees and E. J. M. Campbell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Brain.

In The Last Decade

Phil E M Smith

102 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phil E M Smith United Kingdom 31 1.3k 760 420 345 318 107 2.6k
Bertrand de Toffol France 28 1.4k 1.1× 733 1.0× 237 0.6× 625 1.8× 169 0.5× 181 2.8k
Michael Salzberg Australia 33 920 0.7× 625 0.8× 307 0.7× 893 2.6× 208 0.7× 75 2.6k
Karl O. Nakken Norway 28 2.1k 1.6× 1.5k 2.0× 438 1.0× 740 2.1× 483 1.5× 157 3.0k
Çiğdem Özkara Türkiye 27 1.5k 1.2× 872 1.1× 235 0.6× 616 1.8× 147 0.5× 128 2.4k
Bettina Schmitz Germany 34 2.4k 1.9× 1.6k 2.1× 275 0.7× 764 2.2× 98 0.3× 119 3.5k
Pasquale Parisi Italy 39 3.0k 2.4× 1.6k 2.1× 456 1.1× 601 1.7× 504 1.6× 230 4.9k
A. David Rothner United States 32 1.9k 1.5× 465 0.6× 161 0.4× 372 1.1× 576 1.8× 125 3.2k
Enrique Carrazana United States 22 887 0.7× 776 1.0× 204 0.5× 379 1.1× 207 0.7× 124 2.6k
Sherifa A. Hamed Egypt 31 1.2k 1.0× 949 1.2× 580 1.4× 310 0.9× 304 1.0× 135 3.2k
Per Sidenius Denmark 30 1.3k 1.0× 1.0k 1.3× 314 0.7× 651 1.9× 599 1.9× 62 3.3k

Countries citing papers authored by Phil E M Smith

Since Specialization
Citations

This map shows the geographic impact of Phil E M Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil E M Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil E M Smith more than expected).

Fields of papers citing papers by Phil E M Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil E M Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil E M Smith. The network helps show where Phil E M Smith may publish in the future.

Co-authorship network of co-authors of Phil E M Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Phil E M Smith. A scholar is included among the top collaborators of Phil E M Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil E M Smith. Phil E M Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Phil E M & Sarah Greenfield. (2024). Towards Refined Autism Screening: A Fuzzy Logic Approach with a Focus on Subtle Diagnostic Challenges. Mathematics. 12(13). 2012–2012. 2 indexed citations
3.
Marson, Anthony G, Girvan Burnside, Richard Appleton, et al.. (2021). Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Health Technology Assessment. 25(75). 1–134. 10 indexed citations
4.
Sen, Arjune, Patricia Dugan, Piero Perucca, et al.. (2018). The phenotype of bilateral hippocampal sclerosis and its management in “real life” clinical settings. Epilepsia. 59(7). 1410–1420. 5 indexed citations
5.
Thomas, Rhys H., et al.. (2013). The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugs. Epilepsy & Behavior. 29(3). 492–496. 6 indexed citations
6.
Pickrell, William Owen, Arron Lacey, Rhys H. Thomas, Phil E M Smith, & Mark I. Rees. (2012). Weight change associated with antiepileptic drugs. Journal of Neurology Neurosurgery & Psychiatry. 84(7). 796–799. 53 indexed citations
7.
Smith, Phil E M & S J Wallace. (2012). Clinicians' guide to epilepsy. 4 indexed citations
8.
Baxter, Susan, Rebecca Mayor, Wendy Baird, et al.. (2012). Understanding patient perceptions following a psycho-educational intervention for psychogenic non-epileptic seizures. Epilepsy & Behavior. 23(4). 487–493. 31 indexed citations
9.
Bialer, Meir & Phil E M Smith. (2012). Introduction. Epilepsia. 53(s8). 1–2. 2 indexed citations
10.
Lawthom, Charlotte, Phil E M Smith, & John M. Wild. (2009). Nasal Retinal Nerve Fiber Layer Attenuation: A Biomarker for Vigabatrin Toxicity. Ophthalmology. 116(3). 565–571. 48 indexed citations
11.
Smith, Phil E M, et al.. (2006). The efficacy of acupuncture in the treatment of temporomandibular joint myofascial pain: A randomised controlled trial. Journal of Dentistry. 35(3). 259–267. 90 indexed citations
12.
Razvi, Saif, et al.. (2003). Tilt table testing in patients referred from an epilepsy clinic. Seizure. 12(5). 295–299. 5 indexed citations
13.
Smith, Phil E M, et al.. (2003). Palinopsia. The Lancet. 361(9363). 1098–1098. 7 indexed citations
14.
Smith, Phil E M. (2003). TAKING OVER EPILEPSY FROM THE PAEDIATRIC NEUROLOGIST. Journal of Neurology Neurosurgery & Psychiatry. 74(90001). 37i–41. 6 indexed citations
15.
Smith, Phil E M. (2001). Clinical recommendations for oxcarbazepine. Seizure. 10(2). 87–91. 41 indexed citations
16.
Fuller, Geraint & Phil E M Smith. (2001). Rediscovering the wheel – teaching communication skills using video taped clinical consultations in specialist training. Clinical Medicine. 1(3). 203–205. 7 indexed citations
17.
Phillips, Margaret, Phil E M Smith, N Carroll, R. H. T. Edwards, & Peter Calverley. (1999). Nocturnal Oxygenation and Prognosis in Duchenne Muscular Dystrophy. American Journal of Respiratory and Critical Care Medicine. 160(1). 198–202. 75 indexed citations
18.
Smith, Phil E M & C. M. Wiles. (1998). Cough responsiveness in neurogenic dysphagia. Journal of Neurology Neurosurgery & Psychiatry. 64(3). 385–388. 17 indexed citations
19.
Smith, Phil E M, Peter Calverley, & R. H. T. Edwards. (1988). Hypoxemia during Sleep in Duchenne Muscular Dystrophy. American Review of Respiratory Disease. 137(4). 884–888. 141 indexed citations
20.
Smith, Phil E M. (1970). Management of chemodectomas (glomus jugulare). The Laryngoscope. 80(2). 207–216. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026